Caplin Point Laboratories Ltd. Financials

NSE BSE

15:57 Jul 18

Caplin Point Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2103.30

-6.20 (-0.29%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

2103.30

-6.20 (-0.29%)
15:57 Jul 18

Quality

61/100
High Financial Strength

Valuation

36/100
Mid Valuation

Technical

61/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	1061.29	1269.41	1466.73	1694.1	1937.47
Operating Expenses +	732.65	874.74	1025.67	1142.66	1290.54
Raw Material	389.39	589.43	710.15	798.73	824.15
Increase Decrease in Cost	82.35	-31.92	-46.94	-74.55	-53.31
Other Manufacturing Expense	3.36	0	0	0	0
Employee Cost	102.53	115.3	136.99	143.59	177.72
Miscellaneous Expenses	674.16	996.17	1233.21	1392.73	1493.38
Operating Profit	328.64	394.67	441.06	551.44	646.93
Other Income	23.54	38.75	55.98	66.94	96.43
Depreciation	36.97	46.9	44.99	53.44	65.96
Interest	1.59	0.7	0.78	0.78	0.61
Profit before tax and exceptio..	313.62	385.82	451.27	564.16	676.79
Exceptional Items	0	0	0.08	0.27	0
PBT	313.62	385.82	451.35	564.43	676.79
Provision for Taxation	62.19	77.37	74.36	103.01	135.69
Net Profit	251.43	308.45	376.99	461.42	541.1
NET Profit after MI	242.27	299.84	376.26	457.09	536.31
EPS	31.71	39.61	49.18	60.19	70.25
Operating Profit Margin (%)	30.97	31.09	30.07	32.55	33.39
Net Profit Margin (%)	22.83	23.62	25.65	26.98	27.68

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	70.60	70.60	70.60	70.60	70.60
FII	6.20	5.70	4.90	3.70	3.40
MF	1.90	1.70	1.90	1.60	1.30
Others	0.20	0.30	0.10	0.20	0.10

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: